News
FDA seizes hundreds of fake Ozempic units from US supply after Novo Nordisk alerts regulators to counterfeit semaglutide ...
Ozempic maker Novo Nordisk pushed out its ... In light of the foundation’s request, as well as the company’s recent market challenges and share-price decline, Novo said it jointly concluded ...
Still, while Ozempic and Wegovy have secured status ... “The changes are made in light of the recent market challenges Novo Nordisk has been facing, and the development of the company’s ...
Semaglutide-based drugs are already having an impact on the food industry, according to a leading analyst, and the growing market for alternative proteins could stand to benefit ...
Recent health updates include Texas experiencing a lull in measles cases, Omada’s successful Nasdaq debut, no bird flu ...
Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its first-mover advantage in the competitive obesity drug market to American rival Eli ...
As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...
Ozempic maker Novo Nordisk ousts CEO amid plunging share price as rival Eli Lilly gains market share
Ozempic and Wegovy maker Novo Nordisk ousted ... “The changes are made in light of the recent market challenges Novo Nordisk has been facing, and the development of the company’s share price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results